In October we reported CannPal Animal Therapeutics Limited (ASX:CP1) received ethics approval for a large study in dogs involving THC and CBD. CannPal has developed a medicine called CPAT-01 that the company hopes will be an alternative to Non-Steroidal Anti-Inflammatory (NSAID) drugs; ...
from Google Alert - cbd hemp http://ift.tt/2ppCVgi
via IFTTT ** Interested in building your own business with hemp? Go now! http://ift.tt/SbMGZP **
No comments:
Post a Comment